Allianz Asset Management
FMTX

Allianz Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Allianz Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-34,355
Closed -$963K – 2513
2021
Q1 		$963K Buy
+34,355
New +$1.24M ﹤0.01% 1658

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Allianz Asset Management's FMTX Position: Q2 2021 in Review

Allianz Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q2 2021, closing a stake of 34,355 shares — an estimated $963K sold.

Allianz Asset Management first reported a position in FMTX in Q1 2021 and held it in 1 quarter. The position peaked at $963K in Q1 2021. 82 funds tracked by Wall St. Rank hold FMTX as of Q2 2021.

  • Allianz Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Allianz Asset Management sold 34,355 Forma Therapeutics Holdings, Inc. Common Stock shares in Q2 2021, an estimated $963K.
  • Allianz Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Allianz Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $963K in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q2 2021.

Based on Allianz Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.